Your browser doesn't support javascript.
loading
Impact of Omission/Reduction of Vincristine From R-CHOP in Treatment of DLBCL.
Marshall, Shoko; Nishimura, Noriko; Inoue, Norihito; Yamauchi, Hirofumi; Tsuyama, Naoko; Takeuchi, Kengo; Mishima, Yuko; Yokoyama, Masahiro; Ogasawara, Toshie; Mori, Naoki; Ogawa, Tetsuya; Sakura, Hiroshi; Terui, Yasuhito.
Afiliação
  • Marshall S; Department of Medicine, Tokyo Women's Medical University Medical Center East, Tokyo, Japan; Department of Hematology Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Toyo, Japan. Electronic address: marshall.shoko@twmu.ac.jp.
  • Nishimura N; Department of Hematology Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Toyo, Japan.
  • Inoue N; Department of Hematology Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Toyo, Japan; Division of Pathology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Toyo, Japan.
  • Yamauchi H; Department of Hematology Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Toyo, Japan.
  • Tsuyama N; Division of Pathology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Toyo, Japan.
  • Takeuchi K; Division of Pathology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Toyo, Japan; Pathology Project for Molecular Targets, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Toyo, Japan.
  • Mishima Y; Department of Hematology Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Toyo, Japan.
  • Yokoyama M; Department of Hematology Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Toyo, Japan.
  • Ogasawara T; Department of Medicine, Tokyo Women's Medical University Medical Center East, Tokyo, Japan.
  • Mori N; Department of Medicine, Tokyo Women's Medical University Medical Center East, Tokyo, Japan.
  • Ogawa T; Department of Medicine, Tokyo Women's Medical University Medical Center East, Tokyo, Japan.
  • Sakura H; Department of Medicine, Tokyo Women's Medical University Medical Center East, Tokyo, Japan.
  • Terui Y; Department of Hematology Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Toyo, Japan.
Clin Lymphoma Myeloma Leuk ; 21(3): 162-169, 2021 03.
Article em En | MEDLINE | ID: mdl-33483276
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Difuso de Grandes Células B Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Difuso de Grandes Células B Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article